Blackrock, INC Schedule 13G passive stakes
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting zero beneficial ownership of iShares, Inc. Common Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, indicating it no longer holds a reportable beneficial ownership stake in iShares Trust.
NYSE
BlackRock, Inc. has filed an Amendment No. 19 to its Schedule 13G for iShares Trust, indicating it no longer holds a reportable beneficial ownership stake in the entity as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends iShares, Inc. Beneficial Ownership to Zero Percent in Latest SEC Filing
BlackRock, Inc. has filed an Amendment No. 16 to its Schedule 13G for iShares, Inc., reporting zero beneficial ownership in the common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G indicating it no longer holds any beneficial ownership in Milestone Pharmaceuticals Inc., reducing its stake to 0.0%.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 10.6% beneficial ownership stake in Fidelity National Financial, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 14.7% Stake in Supernus Pharmaceuticals
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 14.7% beneficial ownership stake in Supernus Pharmaceuticals, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 14.2% of American Assets Trust, Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Increases Stake in RLJ Lodging Trust to 10.4%
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 10.4% of RLJ Lodging Trust's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 9 to its Schedule 13G for BlackRock ETF Trust, reporting 0% beneficial ownership as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 4 to Schedule 13G, reporting a 0.0% beneficial ownership stake in iSHARES TRUST Common Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, indicating it no longer holds a beneficial ownership stake in iShares Trust as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock, Inc. Files Amended Schedule 13G, Reporting Zero Beneficial Ownership in BlackRock ETF Trust II
BlackRock, Inc. has filed an amended Schedule 13G, indicating that its beneficial ownership in BlackRock ETF Trust II has fallen below the reporting threshold to 0%.
NYSE
SCHEDULE 13G/A: BlackRock Reports Zero Beneficial Ownership in iShares MSCI France ETF via Amended SEC Filing
BlackRock, Inc. has filed an amended Schedule 13G, reporting zero beneficial ownership of Common Stock in iShares, Inc. (CUSIP 464286707), which appears to refer to the iShares MSCI France ETF, as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock, Inc. Discloses 2.1% Passive Stake in iShares Core U.S. REIT ETF, Subsidiary Holds Over 5%
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 2.1% beneficial ownership stake in iShares Core U.S. REIT ETF as of March 31, 2025, while noting that its subsidiary, BlackRock Japan Co., Ltd., holds over 5% of the class.
NYSE
BlackRock, Inc. has filed an Amendment No. 2 to its Schedule 13G, disclosing a 2.8% beneficial ownership stake in Dun & Bradstreet Holdings, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Files Amended Schedule 13G for iShares Trust, Reporting Zero Beneficial Ownership
BlackRock, Inc. has filed an amended Schedule 13G for iShares Trust, indicating that its beneficial ownership of iShares Trust Common Stock has decreased to zero percent as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 4.4% of AerSale Corp's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G, disclosing a 12.9% beneficial ownership stake in StepStone Group Inc.'s Class A Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 12.6% of Concentra Group Holdings Parent, Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.7% beneficial ownership stake in Sunrise Realty Trust, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Monolithic Power Systems, Disclosing 9.8% Passive Ownership
BlackRock, Inc. has filed an Amendment No. 3 to its Schedule 13G, disclosing a 9.8% passive beneficial ownership stake in Monolithic Power Systems Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 7.2% beneficial ownership stake in Astronics Corp's common stock as of March 31, 2025, held for ordinary course of business.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 9.0% Stake in World Acceptance Corp
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 9.0% in World Acceptance Corp's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.0% Passive Stake in Vitesse Energy, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.0% beneficial ownership stake in Vitesse Energy, Inc. as of March 31, 2025, held for ordinary course investment purposes.
NYSE
BlackRock, Inc. has filed an Amendment No. 3 to its Schedule 13G, reporting a 7.8% beneficial ownership stake in Vimeo, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.0% Stake in NACCO Industries Class A Stock
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 5.0% of NACCO Industries Inc.'s Class A Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing an 11.2% beneficial ownership stake in Pursuit Attractions & Hospitality, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G: BlackRock Discloses 5.4% Passive Stake in Maplebear Inc.
BlackRock, Inc. has filed a Schedule 13G, reporting a passive beneficial ownership of 5.4% of Maplebear Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.0% beneficial ownership stake in Verve Therapeutics, Inc. as of March 31, 2025.